6MK.DE Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 17:35):

Stats
Dagens volum	66.00
Gjennomsnittsvolum	996.00
Markedsverdi	311.51B
EPS	€0 ( 2024-04-24 )
Neste inntjeningsdato	( €0 ) 2024-05-28
Last Dividend	€0.730 ( 2023-09-14 )
Next Dividend	€0 ( N/A )
P/E	146.43
ATR14	€0.503 (0.41%)

Merck & Co Inc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Merck & Co Inc Økonomi

Annual	2023
Omsetning:	€60.12B
Bruttogevinst:	€43.99B (73.17 %)
EPS:	€0.140

FY	2023
Omsetning:	€60.12B
Bruttogevinst:	€43.99B (73.17 %)
EPS:	€0.140

FY	2022
Omsetning:	€59.28B
Bruttogevinst:	€41.87B (70.63 %)
EPS:	€5.72

FY	2021
Omsetning:	€48.70B
Bruttogevinst:	€35.08B (72.02 %)
EPS:	€5.14

Financial Reports:

No articles found.

Merck & Co Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0.690 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Merck & Co Inc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.55 - Stable (30.93%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.380	2009-12-11
Last Dividend	€0.730	2023-09-14
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	56	--
Total Paid Out	€28.56	--
Avg. Dividend % Per Year	0.00%	--
Score	4.6	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.55
Div. Directional Score	8.48	--

Next Divdend (Est)
(2024-07-01)

€0.745 Estimate 22.11 %

Dividend Stability

0.59 Average

Dividend Score

4.60

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
RIO1.DE	Ex Dividend Knight	2023-08-10	Semi-Annually	0.00%
BST.DE	Ex Dividend Junior	2023-09-14	Sporadic	0.00%
JNJ.DE	Ex Dividend Knight	2023-08-25	Quarterly	0.00%
TA1.DE	Ex Dividend Knight	2023-06-12	Annually	0.00%
DEF.DE	Ex Dividend Knight	2023-07-24	Annually	0.00%
MMM.DE	Ex Dividend Junior	2023-08-18	Quarterly	0.00%
4I1.DE	Ex Dividend Knight	2023-09-26	Quarterly	0.00%
VVD.DE	Ex Dividend Knight	2023-05-09	Annually	0.00%
EVK.DE	Ex Dividend Junior	2023-06-01	Annually	0.00%
OMV.DE	Ex Dividend Knight	2023-06-06	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.00607	1.500	9.88	10.00	[0 - 0.5]
returnOnAssetsTTM	0.00342	1.200	9.89	10.00	[0 - 0.3]
returnOnEquityTTM	0.00888	1.500	-1.012	-1.519	[0.1 - 1]
payoutRatioTTM	20.40	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.252	0.800	8.74	6.99	[1 - 3]
quickRatioTTM	0.679	0.800	-0.713	-0.570	[0.8 - 2.5]
cashRatioTTM	0.266	1.500	9.63	10.00	[0.2 - 2]
debtRatioTTM	0.329	-1.500	4.52	-6.78	[0 - 0.6]
interestCoverageTTM	3.18	1.000	9.93	9.93	[3 - 30]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.61	2.00	8.20	10.00	[0 - 20]
debtEquityRatioTTM	0.933	-1.500	6.27	-9.40	[0 - 2.5]
grossProfitMarginTTM	0.732	1.000	1.138	1.138	[0.2 - 0.8]
operatingProfitMarginTTM	0.0598	1.000	-0.804	-0.804	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.371	1.000	9.05	9.05	[0.2 - 2]
assetTurnoverTTM	0.564	0.800	9.58	7.66	[0.5 - 2]
Total Score				10.41

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	913.22	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.00888	2.50	-0.651	-1.519	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.61	2.00	8.80	10.00	[0 - 30]
dividendYielPercentageTTM	2.28	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
payoutRatioTTM	20.40	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	46.09	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.216	1.000	7.09	0	[0.1 - 0.5]
Total Score				6.55

Merck & Co Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.